Piermichele Kobauri

Piermichele Kobauri


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PKPiermichele Kobauri
Piermichele Kobauri
Frank DekkerFrank Dekker
Frank Dekker
WSWiktor Szymanski
Wiktor Szymanski
BFBen Feringa
Ben Feringa
Photopharmacology is an attractive approach for achieving targeted drug action with the use of light. In photopharmacology, molecular photoswitches are introduced into the structure of biologically active small molecules to allow for the optical control of their potency. Going beyond trial and error, photopharmacology has progressively applied rational drug design methodologies to devise light‐controlled bioactive ligands. In this review, we categorize photopharmacological efforts from the standpoint of medicinal chemistry strategies, focusing on diffusible photochromic ligands modified with photoswitches that operate through E‐Z bond isomerization. In the vast majority of cases, photoswitchable ligands are designed as analogs of existing compounds, through a variety of approaches. By analyzing in detail a comprehensive list of instructive examples, we describe the state of the art and discuss future opportunities for rational design in photopharmacology.

27 May 2021 in Chemical Science
Verified
Journal Article
Open access
PDF file
NSNadja A. Simeth
Nadja A. Simeth
SKShotaro Kobayashi
Shotaro Kobayashi
PKPiermichele Kobauri
Piermichele Kobauri
SCStefano Crespi
Stefano Crespi
WSWiktor Szymanski
Wiktor Szymanski
BFBen Feringa
Ben Feringa
Short, complementary DNA single strands with mismatched base pairs cannot undergo spontaneous formation of duplex DNA (dsDNA). Mismatch binding ligands (MBLs) can compensate this effect, inducing the formation of the double helix and thereby acting as a molecular glue. Here, we present the rational design of photoswitchable MBLs that allow for reversible dsDNA assembly by light. Careful choice of the azobenzene core structure results in excellent band separation of the E and Z isomers of the involved chromophores. This effect allows for efficient use of light as an external control element for duplex DNA formation and for an in-depth study of the DNA–ligand interaction by UV-Vis, SPR, and CD spectroscopy, revealing a tight mutual interaction and complementarity between the photoswitchable ligand and the mismatched DNA. We also show that the configuration of the switch reversibly dictates the conformation of the DNA strands, while the dsDNA serves as a chiral clamp and translates its chiral information onto the ligand inducing a preference in helical chirality of the Z isomer of the MBLs.

4 May 2023 in Angewandte Chemie
Verified
Journal Article
Open access
PKPiermichele Kobauri
Piermichele Kobauri
Frank DekkerFrank Dekker
Frank Dekker
WSWiktor Szymanski
Wiktor Szymanski
BFBen Feringa
Ben Feringa
Photopharmacology is an attractive approach for achieving targeted drug action with the use of light. In photopharmacology, molecular photoswitches are introduced into the structure of biologically active small molecules to allow for the optical control of their potency. Going beyond trial and error, photopharmacology has progressively applied rational drug design methodologies to devise light‐controlled bioactive ligands. In this review, we categorize photopharmacological efforts from the standpoint of medicinal chemistry strategies, focusing on diffusible photochromic ligands modified with photoswitches that operate through E‐Z bond isomerization. In the vast majority of cases, photoswitchable ligands are designed as analogs of existing compounds, through a variety of approaches. By analyzing in detail a comprehensive list of instructive examples, we describe the state of the art and discuss future opportunities for rational design in photopharmacology.

18 March 2021 in Chemical Communications
Verified
Journal Article
Open access
PDF file
PKPiermichele Kobauri
Piermichele Kobauri
WSWiktor Szymanski
Wiktor Szymanski
FCFangyuan Cao
Fangyuan Cao
STSebastian Thallmair
Sebastian Thallmair
SMSiewert-Jan Marrink
Siewert-Jan Marrink
BFBen Feringa
Ben Feringa
Biaryl sulfonamides are excellent candidates for the azologization approach that yields photoswitchable drugs more active in their metastable cis state, compared to the stable trans state. Here we present the scope and limitations of this strategy for rational design in photopharmacology.

21 April 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Anna LauxenAnna Lauxen
Anna Lauxen
PKPiermichele Kobauri
Piermichele Kobauri
MWMichael Wegener
Michael Wegener
MHMickel J. Hansen
Mickel J. Hansen
NGNicole Galenkamp
Nicole Galenkamp
OKOscar Kuipers
Oscar Kuipers
During the last decades, a continuous rise of multi-drug resistant pathogens has threatened antibiotic efficacy. To tackle this key challenge, novel antimicrobial therapies are needed with increased specificity for the site of infection. Photopharmacology could enable such specificity by allowing for the control of antibiotic activity with light, as exemplified by trans/cis-tetra-ortho-chloroazobenzene-trimethoprim (TCAT) conjugates. Resistance development against the on (irradiated, TCATa) and off (thermally adapted, TCATd) states of TCAT were compared to that of trimethoprim (TMP) in Escherichia coli mutant strain CS1562. Genomics and transcriptomics were used to explore the acquired resistance. Although TCAT shows TMP-like dihydrofolate reductase (DHFR) inhibition in vitro, transcriptome analyses show different responses in acquired resistance. Resistance against TCATa (on) relies on the production of exopolysaccharides and overexpression of TolC. While resistance against TCATd (off) follows a slightly different gene expression profile, both indicate hampering the entrance of the molecule into the cell. Conversely, resistance against TMP is based on alterations in cell metabolism towards a more persister-like phenotype, as well as alteration of expression levels of enzymes involved in the folate biosynthesis. This study provides a deeper understanding of the development of new therapeutic strategies and the consequences on resistance development against photopharmacological drugs.

22 April 2022
Verified
Thesis
Closed access
PDF file
PKPiermichele Kobauri
Piermichele Kobauri